arXiv · 2509.00937
Parallelizing Drug Discovery: HPC Pipelines for Alzheimer's Molecular Docking and Simulation
Abstract
High-performance computing (HPC) is reshaping computational drug discovery by enabling large-scale, time-efficient molecular simulations. In this work, we explore HPC-driven pipelines for Alzheimer's disease drug discovery, focusing on virtual screening, molecular docking, and molecular dynamics simulations. We implemented a parallelised workflow using GROMACS with hybrid MPI-OpenMP strategies, benchmarking scaling performance across energy minimisation, equilibration, and production stages. Additionally, we developed a docking prototype that demonstrates significant runtime gains when moving from sequential execution to process-based parallelism using Python's multiprocessing library. Case studies on prolinamide derivatives and baicalein highlight the biological relevance of these workflows in targeting amyloid-beta and tau proteins. While limitations remain in data management, computational costs, and scaling efficiency, our results underline the potential of HPC to accelerate neurodegenerative drug discovery.
Explore related subjects
Keep this discovery
Paul Ruiz Alliata, Diana Rubaga, Daniel Kumlin, Alberto Puliga. 2025-08-31. Parallelizing Drug Discovery: HPC Pipelines for Alzheimer's Molecular Docking and Simulation. https://arxiv.org/abs/2509.00937
Cite the original work for its findings. Save a collection to share your selection of sources.